Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Tripos, CombinatoRx team up to optimize novel compounds
September 2007
SHARING OPTIONS:

RICHMOND, Va.Tripos Discovery Research Limited (TDR), a wholly owned subsidiary of Commonwealth Biotechnologies Inc. (CBI) and a leading provider of drug discovery chemistry services and small molecule products, has entered into a service agreement with CombinatoRx Inc., a company specializing in the field of synergistic combination pharmaceuticals.
Using its combination high-throughput screening technology, cHTS, CombinatoRx has identified synergistic combinations with utility in key indications which TDR will optimize utilizing its expertise in computational and medicinal chemistry and partner ADME services.
 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.